Evolent Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 09:35:42 ET EVH

Published on 05/07/2026 at 09:35 am EDT

Evolent Health, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 496.25 million compared to USD 483.65 million a year ago. Net loss was USD 26.63 million compared to USD 64.62 million a year ago.

Basic loss per share from continuing operations was USD 0.24 compared to USD 0.63 a year ago. Diluted loss per share from continuing operations was USD 0.24 compared to USD 0.63 a year ago.